Blog
RSS FeedPosted by Michael Wonder on 30 Sep 2022
Schedule of Pharmaceutical Benefits - 1 October 2022
1 October 2022 - The October 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Sep 2022
TGA grants provisional determination to Moderna’s COVID-19 bivalent (Original plus Omicron BA.4/BA.5) booster dose vaccine
30 September 2022 - On 28 September 2022, the TGA granted a provisional determination to Moderna's bivalent COVID-19 vaccine candidate: elasomeran ...
Posted by Michael Wonder on 29 Sep 2022
TGA provisionally approves Pfizer’s COVID-19 vaccine, Comirnaty (tozinameran) for use in children aged 6 months to less than 5 years
29 September 2022 - On 29 September 2022, the TGA provisionally approved a paediatric dose of Pfizer’s COVID-19 vaccine, Comirnaty (tozinameran), ...
Posted by Michael Wonder on 27 Sep 2022
COVID-19 vaccine procurement review says rapid access to vaccines and treatments key to on-going protection of Australians
27 September 2022 - Medicines Australia welcomes the independent review of Australia’s COVID-19 vaccine and treatment procurements by Professor Jane ...
Posted by Michael Wonder on 27 Sep 2022
Half of GPs say staying open is financially unsustainable as Medicare rebate fails
28 September 2022 - Staying in general practice is financially unsustainable for almost half of the nation’s GPs due to ...
Posted by Michael Wonder on 27 Sep 2022
Halton review into vaccine and treatment procurement
27 September 2022 - Professor Jane Halton AO has handed to Government her independent review of Australia’s COVID-19 vaccine and treatment ...
Posted by Michael Wonder on 26 Sep 2022
Patients will pay less for critical medicines including ‘miracle’ cancer drug
26 September 2022 - Australians will have cheaper access to medicines for migraines, arthritis, bipolar, stomach ulcers and several cancers. ...
Posted by Michael Wonder on 26 Sep 2022
Novavax appeals to ATAGI to change advice as vaccine uptake falls behind
25 September 2022 - Novavax was hailed as the fix to Australia’s low inoculation rate and “the vaccine for anti-vaxxers”. So ...
Posted by Michael Wonder on 26 Sep 2022
Australians have access to more affordable and life changing medicines on PBS
26 September 2022 - From 1 October 2022, Australians will pay less at the pharmacy for new and updated medicines on ...
Posted by Michael Wonder on 26 Sep 2022
ATAGI recommend the COVID-19 vaccination for some children aged 6 months to under 5 years
26 September 2022 - Australia’s immunisation experts, the Australian Technical Advisory Group on Immunisation, recommend COVID-19 vaccination for some children aged ...
Posted by Michael Wonder on 26 Sep 2022
National Medicines Policy draft strides ahead but still room for improvement
26 September 2022 - Stakeholders have until tomorrow night to submit their feedback on the refreshed National Medicines Policy that ...
Posted by Michael Wonder on 22 Sep 2022
13 million Novavax doses due to expire as Australians stick to mRNA boosters
21 September 2022 - Novavax COVID vaccines procured by the federal government in the hopes of convincing hesitant Australians to ...
Posted by Michael Wonder on 21 Sep 2022
TGA provisionally approves Pfizer's COVID-19 vaccine, Comirnaty (tozinameran), for use as a booster dose in individuals 5 years and older
21 September 2022 - On 20 September 2022, the TGA provisionally approved Pfizer's COVID-19 vaccine, Comirnaty (tozinameran) for use as ...
Posted by Michael Wonder on 20 Sep 2022
Insurer to return $40 million in health care claims to 600,000 Aussies
20 September 2022 - Health insurance company nib is returning $40 million in health care claims to more than 600,000 ...
Posted by Michael Wonder on 19 Sep 2022
2022 October price disclosure cycle – confirmed prices and patient savings reports
19 September 2022 - Confirmed prices reports for brands to be reduced on 1 October 2022 have now been published on ...